Rhinomed RHNMF Stock
Rhinomed Price Chart
Rhinomed RHNMF Financial and Trading Overview
| Rhinomed stock price | 0.02 USD |
| Previous Close | 0.04 USD |
| Open | 0.04 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.04 - 0.04 USD |
| 52 Week Range | 0.03 - 0.15 USD |
| Volume | 500 USD |
| Avg. Volume | 2.13K USD |
| Market Cap | 13.54M USD |
| Beta (5Y Monthly) | 0.76475 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RHNMF Valuation Measures
| Enterprise Value | 13.48M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4387757 |
| Price/Book (mrq) | 43.299995 |
| Enterprise Value/Revenue | 1.433 |
| Enterprise Value/EBITDA | -2.031 |
Trading Information
Rhinomed Stock Price History
| Beta (5Y Monthly) | 0.76475 |
| 52-Week Change | -56.39% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.15 USD |
| 52 Week Low | 0.03 USD |
| 50-Day Moving Average | 0.05 USD |
| 200-Day Moving Average | 0.07 USD |
RHNMF Share Statistics
| Avg. Volume (3 month) | 2.13K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 285.72M |
| Float | 80.03M |
| Short Ratio | N/A |
| % Held by Insiders | 70.30% |
| % Held by Institutions | 0.60% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -71.054% |
| Operating Margin (ttm) | -78.00000000000000000000000000000000% |
| Gross Margin | 71.91% |
| EBITDA Margin | -70.53% |
Management Effectiveness
| Return on Assets (ttm) | -58.19% |
| Return on Equity (ttm) | -388.12% |
Income Statement
| Revenue (ttm) | 9.41M USD |
| Revenue Per Share (ttm) | 0.03 USD |
| Quarterly Revenue Growth (yoy) | -5.00000000000000000000000000000000% |
| Gross Profit (ttm) | 6.71M USD |
| EBITDA | -6636798 USD |
| Net Income Avi to Common (ttm) | -6685503 USD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.63M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 4.74M USD |
| Total Debt/Equity (mrq) | 2261.76 USD |
| Current Ratio (mrq) | 0.761 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6306406 USD |
| Levered Free Cash Flow (ttm) | -3946494 USD |
Profile of Rhinomed
| Country | United States |
| State | VIC |
| City | Cremorne |
| Address | 132 Gwynne Street |
| ZIP | 3121 |
| Phone | 61 3 8416 0900 |
| Website | https://www.rhinomed.global |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It offers wearable nasal technology that improve breathing, sleeping, and maintaining health and diagnose disease. The company's products include Turbine for enhanced breathing in sports; Mute, which helps to breath more and snore less; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab that is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is headquartered in Cremorne, Australia.
Q&A For Rhinomed Stock
What is a current RHNMF stock price?
Rhinomed RHNMF stock price today per share is 0.02 USD.
How to purchase Rhinomed stock?
You can buy RHNMF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rhinomed?
The stock symbol or ticker of Rhinomed is RHNMF.
Which industry does the Rhinomed company belong to?
The Rhinomed industry is Medical Devices.
How many shares does Rhinomed have in circulation?
The max supply of Rhinomed shares is 286.78M.
What is Rhinomed Price to Earnings Ratio (PE Ratio)?
Rhinomed PE Ratio is 0.00000000 now.
What was Rhinomed earnings per share over the trailing 12 months (TTM)?
Rhinomed EPS is 0 USD over the trailing 12 months.
Which sector does the Rhinomed company belong to?
The Rhinomed sector is Healthcare.